Sapporo Clinical Laboratory Inc. (9776) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sapporo Clinical Laboratory Inc. (9776:JPX), powered by AI.

Current Price
¥1,952
P/E Ratio
13.2
Market Cap
6.1B
Sector
Healthcare
What is the Sapporo Clinical Laboratory Inc. stock price forecast?

Sapporo Clinical Laboratory Inc. is currently trading at ¥1,952. View real-time AI analysis on Alpha Lenz.

What is Sapporo Clinical Laboratory Inc. insider trading activity?

View the latest insider trading data for Sapporo Clinical Laboratory Inc. on Alpha Lenz.

What is Sapporo Clinical Laboratory Inc.'s P/E ratio?

Sapporo Clinical Laboratory Inc.'s P/E ratio is 13.2.

Sapporo Clinical Laboratory Inc.

JPX · 9776
¥1,952-8(-0.41%)Market closedJPX regular session 09:00–15:00 JST
Ask about Sapporo Clinical Laboratory Inc.'s future dividend policy...
Alpha Chat Insight

Sapporo Clinical Laboratory Inc. trades at a P/E of 13.2 (undervalued) with modest ROE of 4.2%.

Ask for details

Company Overview

Sapporo Clinical Laboratory Inc. operates as a key player in the healthcare industry, focusing on providing clinical testing services essential for medical diagnostics and healthcare solutions. This company specializes in offering a wide range of medical examinations, including biochemical tests, hematological analysis, and microbiological assessments, serving both hospitals and medical practitioners. By delivering precise and timely diagnostic information, Sapporo Clinical Laboratory supports the healthcare sector in ensuring accurate disease diagnoses and effective treatment planning. As healthcare demands continue to grow, the company’s role is increasingly pivotal, contributing significantly to public health management and patient care improvement. Based in Sapporo, Japan, the company combines advanced laboratory technology with expert knowledge to maintain high standards in clinical diagnostics. This commitment not only fortifies its market presence but also elevates its impact within the broader healthcare infrastructure, particularly in Japan, where there is an ongoing emphasis on improving healthcare quality and accessibility.

CEOMr. Tadamasa Date
SectorHealthcare
IndustryPharmaceutical Retailers
Employees879

Company Statistics

FY 2025

Profile

¥6,107,770,912Market Cap
¥20,131,372,000Revenue
0.00Shares Out
879Employees

Margins

30.51%Gross
6.32%EBITDA
3.51%Operating
3.48%Pre-Tax
2.28%Net

Valuation

13.16P/E
0.55P/B
0.30EV/Sales
4.20EV/EBITDA
-11.19P/FCF

Growth (CAGR)

1.75%Rev 3Yr
2.66%Rev 5Yr
-22.84%Op Inc 3Yr
-5.66%Op Inc 5Yr
-24.08%Net Inc 3Yr
-2.81%Net Inc 5Yr

Returns

2.76%ROA
4.20%ROE
4.26%ROIC

Financial Health

¥2,941,239,000Cash & Cash Equivalents
¥2,115,584,000Net Debt
44.38%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Sapporo Clinical Laboratory Inc. (ticker: 9776) is a company listed on JPX in the Healthcare sector (Pharmaceutical Retailers). It has approximately 879 employees. Market cap is $6.1B.

The current price is 1,952 with a P/E ratio of 13.16x and P/B of 0.55x.

ROE is 4.20% and operating margin is 3.51%. Annual revenue is $20.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Sapporo Clinical Laboratory Inc. (9776) Stock Forecast 2026 ¥1,952 — Price, Financials & Analyst Targets | Alpha Lenz